Boston Scientific's Filterwire EX
This article was originally published in The Gray Sheet
Executive Summary
Embolic protection device receives European CE mark for use in coronary and saphenous vein graft procedures. CE marked in October for peripheral use, the filter system was developed by Embolic Protection, Inc. Boston Scientific completed its $75 mil. acquisition of EPI on Feb. 27 (1"The Gray Sheet" Feb. 26, 2001, p. 9)